Clinical Trials in Illinois

Showing 5161-5180 of 19,692 trials

INTEGRATED CHILDHOOD ACTIVITY AND NUTRITION (ICAN) STUDY

NCT07011602

This study is a multi-functional integrated research and education project to prevent losses in academic achievement, cognitive function, and behavioral health among at-risk youth. The study tests the effects of a 8-week nutrition and physical activity-based program (Integrated Childhood Activity and Nutrition \[ICAN\]) to prevent summer learning loss. Outcomes include standardized academic achievement as well as executive function among 6-10-year-olds affected by poverty. The nutrition component of the intervention involves daily consumption of a snack containing the carotenoid lutein, typically found in high quantities in green leafy vegetables. The physical activity components will involve group games or activities.

AchievementWeight ChangeCognition+2 more

University of Illinois at Urbana-Champaign100 participantsStarted Jun 2025

Bloomington, Illinois, United States

Active Not RecruitingPhase 311 miles

A 52-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough

NCT05599191

This is a randomized, double-blind, placebo-controlled, parallel-arm, Phase 3 study of BLU-5937 in participants with Refractory Chronic Cough (RCC).

CoughRefractory Chronic Cough

Bellus Health Inc. - a GSK company825 participantsStarted Oct 2022

Litchfield Park, Arizona, United States • Scottsdale, Arizona, United States • Encinitas, California, United States +188 more locations

INTEGRATED CHILDHOOD ACTIVITY AND NUTRITION (ICAN) STUDY

A 52-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough

Find Trials by Condition in Illinois

TRIcvalve biCAVal Valve System for Severe Tricuspid Regurgitation (TRICAV-I)

Alzheimer's Plasma Extension

TAC T-cells for the Treatment of HER2-positive Solid Tumors

Study of Orally Administered AG-120 in Subjects With Advanced Hematologic Malignancies With an IDH1 Mutation

A Study ATG-101 in Patients With Metastatic/Advanced Solid Tumors and Mature B-cell Non-Hodgkin Lymphomas

Promoting Shared Decision Making for Severe Aortic Stenosis

ProVIDE II Bridging Study

Study of the Efficacy and Safety PF-06741086 in Adult and Teenage Participants With Severe Hemophilia A or Moderately Severe to Severe Hemophilia B

JAGUAR Trial: ObJective Analysis to GaUge EVAR Outcomes Through Randomization

Understanding the Natural History Early in the Course or Presentation of Friedreich Ataxia

Nemvaleukin Alfa Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Cutaneous or Mucosal Melanoma - ARTISTRY-6

Trial of Newly Diagnosed High Grade Glioma Treated With Concurrent Radiation Therapy, Temozolomide and BMX-001

Validation of a Multi-gene Test for Lung Cancer Risk

ZZ06 in Adult Patients With Advanced Solid Tumor Malignancies

Tolerability of the Combination of Lapatinib and Trastuzumab in Adults Age 60 or Older With HER2 Positive Locally Advanced or Metastatic Breast Cancer

Study of Neoadjuvant Olaparib Monotherapy and Olaparib and Durvalumab Combination in HER2 Negative BRCAm Breast Cancer

VB-111 in Surgically Accessible Recurrent/Progressive GBM

Study to Evaluate Safety and Immunogenicity of a Prime-Boost Regimen of rVSV-Nipah Virus Vaccine Candidate PHV02 in Healthy Adult Subjects